title: Breast cancer stem cells: treatment resistance and therapeutic opportunities.
abstract: The clinical and pathologic heterogeneity of human breast cancer has long been recognized. Now, molecular profiling has enriched our understanding of breast cancer heterogeneity and yielded new prognostic and predictive information. Despite recent therapeutic advances, including the HER2-specific agent, trastuzumab, locoregional and systemic disease recurrence remain an ever-present threat to the health and well being of breast cancer survivors. By definition, disease recurrence originates from residual treatment-resistant cells, which regenerate at least the initial breast cancer phenotype. The discovery of the normal breast stem cell has re-ignited interest in the identity and properties of breast cancer stem-like cells and the relationship of these cells to the repopulating ability of treatment-resistant cells. The cancer stem cell model of breast cancer development contrasts with the clonal evolution model, whereas the mixed model draws on features of both. Although the origin and identity of breast cancer stem-like cells is contentious, treatment-resistant cells survive and propagate only because aberrant and potentially druggable signaling pathways are recruited. As a means to increase the rates of breast cancer cure, several approaches to specific targeting of the treatment-resistant cell population exist and include methods for addressing the problem of radioresistance in particular.
authors.affiliation: Signal Transduction Lab, Queensland Institute of Medical Research, 300 Herston Road, Brisbane, Queensland 4006, Australia.
authors.forename: Fares
authors.initials: F
authors.lastname: Al-Ejeh
authors.forename: Chanel E
authors.initials: CE
authors.lastname: Smart
authors.forename: Brian J
authors.initials: BJ
authors.lastname: Morrison
authors.forename: Georgia
authors.initials: G
authors.lastname: Chenevix-Trench
authors.forename: J Alejandro
authors.initials: JA
authors.lastname: López
authors.forename: Sunil R
authors.initials: SR
authors.lastname: Lakhani
authors.forename: Michael P
authors.initials: MP
authors.lastname: Brown
authors.forename: Kum Kum
authors.initials: KK
authors.lastname: Khanna
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D014411:Neoplastic Stem Cells / Q000187:drug effects*; D015398:Signal Transduction